Valuation: VISD GP

Market Cap 5.5Cr 6.29Cr 5.05Cr 4.71Cr 8.93Cr 598.5Cr 9.06Cr 61Cr 24Cr 294.2Cr 24Cr 23Cr 1.01TCr P/E 2024
44.3x
P/E 2025 31.3x
Enterprise Value 5.51Cr 6.3Cr 5.06Cr 4.72Cr 8.95Cr 599.86Cr 9.08Cr 61Cr 24Cr 294.86Cr 24Cr 23Cr 1.02TCr EV / Sales 2024
3.3x
EV / Sales 2025 3.04x
Free-Float
99.83%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 36 22/01/2024
Investor Relations Contact - -
Chief Executive Officer - 01/04/2022
Director TitleAgeSince
Chairman - -
Director/Board Member - 01/04/2022
Director/Board Member 51 14/06/2023
Change 5-day change 1-year change 3-year change Capi.($)
-0.09%+0.36%+55.30%+50.48% 13TCr
+4.39%+4.80%+9.01%+37.59% 9.11TCr
+1.04%+8.95%+1.27%+73.55% 2.73TCr
-0.14%+2.78%+21.93%+56.09% 2.39TCr
+0.09%+3.18%-19.07%-24.15% 2.03TCr
+6.55%+7.79%+18.79%+153.04% 1.75TCr
+0.62%+3.00%+2.35%+11.27% 1.52TCr
+3.02%+8.23%+64.78%+131.76% 1.51TCr
+0.84%+4.75%-13.56%-3.31% 1.26TCr
Average +1.45%+4.88%+15.64%+54.03% 3.96TCr
Weighted average by Cap. +1.46%+3.62%+26.78%+50.00%

Financials

2024 2025
Net sales 1.73Cr 1.97Cr 1.59Cr 1.48Cr 2.8Cr 187.99Cr 2.85Cr 19Cr 7.4Cr 92Cr 7.41Cr 7.25Cr 318.43Cr 2.22Cr 2.54Cr 2.04Cr 1.9Cr 3.6Cr 241.42Cr 3.66Cr 24Cr 9.51Cr 118.67Cr 9.52Cr 9.31Cr 408.94Cr
Net income 14.05L 16.07L 12.91L 12.04L 22.83L 15Cr 23.17L 1.55Cr 60.26L 7.52Cr 60.33L 59.03L 26Cr 22.81L 26.09L 20.96L 19.54L 37.06L 25Cr 37.62L 2.52Cr 97.83L 12Cr 97.94L 95.84L 42Cr
Net Debt 25.75L 29.46L 23.66L 22.06L 41.84L 28Cr 42.47L 2.84Cr 1.1Cr 14Cr 1.11Cr 1.08Cr 48Cr 1L 1L 1L 1L 2L 1.36Cr 2L 13.79L 5L 66.92L 5L 5L 2.31Cr
Logo VISD GP
Founded in 2007, Klea Holding is a group focused on acquiring, developing and digitizing companies in various sectors to maximize their growth and value. Through its "scaling industries of the future" identity, Klea Holding draws on its successful experience in developing Smart Salem, the first network of digitalized medical analysis centers accredited by the Dubai Ministry of Health (DHA) in the United Arab Emirates, its joint venture Smart Health, dedicated to the roll-out of digital medical testing centres in Saudi Arabia; and Klea Pharmaceuticals, a subsidiary dedicated to the commercialisation of a portfolio of licensed medicines in the Middle East and Africa.
Employees
-